Logged in as: Guest
WCN'24 Home
View detailed Congress Program
View Program at a glance
LOGIN
ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/94a3890bcf387386a810a07393b3318e.pdf
Abstract Title
ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY
First Name *
Jonathan
Last Name *
Barratt
Co-author 1
Bart Maes bart.maes@azdelta.be AZ Delta Nephrology Roeselare
Co-author 2
Celia Lin celia.lin@veratx.com Vera Therapeutics Medical Brisbane
Co-author 3
Xuelian Wei xuelian.wei@veratx.com Vera Therapeutics Biostatistics Brisbane
Co-author 4
Sean Barbour sean.barbour@vch.ca University of British Columbia Nephrology Vancouver
Co-author 5
Richard Phoon richard.phoon@sydney.edu.au University of Sydney Nephrology Sydney
Co-author 6
Sung Gyun Kim imnksk@gmail.com Hallym University Sacred Heart Hospital Nephrology Gyeonggi-do
Co-author 7
Vladimir Tesar vladimir.tesar@vfn.cz Charles University Nephrology Prague
Co-author 8
Jürgen Floege jfloege@ukaachen.de RWTH Aachen University Hospital Nephrology Aachen
Co-author 9
Vivekanand Jha vjha@georgeinstitute.org.in The George Institute for Global Health India Nephrology New Delhi
Co-author 10
Richard Lafayette czar@stanford.edu Stanford University Nephrology Stanford
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
